Mr Michael Robert Kendall Clayton

business executiveBRITISHUNITED KINGDOMBorn April 1974

Current Appointments
22

Lingo Technology Uk Limited

director · Since 02/12/2022

Active
Abbott Healthcare Connections Limited

director · Since 16/05/2022

Active
Abbott Uk Subsidiary 2 Limited

director · Since 14/12/2021

Abbott Uk Subsidiary Limited

director · Since 08/12/2021

Active
Abbott Laboratories Limited

director · Since 23/03/2020

Active
Abbott Healthcare Products Ltd

director · Since 23/03/2020

Active
Mansbridge Pharmaceuticals Limited

director · Since 23/03/2020

Abbott (Uk) Holdings Limited

director · Since 23/03/2020

Active
Abbott (Uk) Finance Limited

director · Since 23/03/2020

Active
Gynocare Limited

director · Since 23/03/2020

Active
Abbott Equity Holdings Unlimited

director · Since 23/03/2020

Active
Abbott Vascular Devices Limited

director · Since 23/03/2020

Active
Abbott Capital India Limited

director · Since 23/03/2020

Active
Abbott Vascular Devices (2) Limited

director · Since 23/03/2020

Active
Knoll Uk Investments Unlimited

director · Since 23/03/2020

Active
Abbott Asia Investments Limited

director · Since 23/03/2020

Active
Abbott Australasia Holdings Limited

director · Since 23/03/2020

Active
Abbott Uk Investments Limited

director · Since 23/03/2020

Active
Abbott Asia Holdings Limited

director · Since 23/03/2020

Active
Fournier Pharmaceuticals Limited

director · Since 23/03/2020

Murex Biotech Limited

director · Since 23/03/2020

Active
British Colloids Limited

director · Since 23/03/2020

Active

Summary

Current roles22
Former roles0
Occupationbusiness executive
NationalityBRITISH
Based inUNITED KINGDOM
DOBBorn April 1974
Risk flags None detected

Financial FootprintActive cos.

Combined net worth£81k

Based on latest filed accounts for 1 of 22 active companies.

Data sourced from Companies House public register. Financial data from filed accounts. Updated as filings are processed.